After a career in various legal positions in international consumer goods and pharmaceutical companies, Michael Kuner joined Altana Pharma in 2001 as Senior Legal Counsel. When Nycomed acquired Altana Pharma, he was appointed Senior Vice President & General Counsel, reporting to Chief Executive Officer Håkan Björklund.

Michael Kuner is a law graduate from the University of Freiburg and is admitted to the German bar, he has more than 17 years’ experience in multinational pharmaceutical companies.

“I am really pleased that Michael is joining the Executive Committee”, said Nycomed Chief Executive Officer, Håkan Björklund. “To have such experienced legal advice close at hand is a great asset”, he continued.

Nycomed is a pharmaceutical company that provides medicines for hospitals, specialists and general practitioners, as well as over-the-counter medicines in selected markets.

The company is active within a range of therapeutic areas, including cardiology, gastroenterology, osteoporosis, respiratory, pain and tissue management. New products are sourced both from own research and from external partners. Operating throughout Europe and in fast-growing markets such as Latin America, Russia/CIS and the Asia-Pacific region Nycomed has a presence in about 50 markets worldwide.

Privately owned, the combined group had annual sales of approximately € 3.4 billion and an EBITDA of € 933.4 million (2006 results).

Source: Nycomed - 19.02.08 (P)

Further Information:
Investors:
Christian B. Seidelin, Vice President Controlling, Treasury and Insurance
Phone: +41 (0) 44 55511-04
Media:
Tobias Cottmann, Director External Communications
Phone: +41 (0)44 55515-10